SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-310167
Filing Date
2022-12-21
Accepted
2022-12-21 17:23:45
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d423180d424b5.htm 424B5 324716
2 GRAPHIC g423180g01a01.jpg GRAPHIC 60850
3 GRAPHIC g423180g01a20.jpg GRAPHIC 70117
4 GRAPHIC g423180g02v00.jpg GRAPHIC 33632
  Complete submission text file 0001193125-22-310167.txt   548963
Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Filer) CIK: 0001796280 (see all company filings)

IRS No.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-255833 | Film No.: 221479181
SIC: 2834 Pharmaceutical Preparations